San Diego, CA -- (SBWIRE) -- 08/11/2015 -- An investigation for NYSE:CYT shareholders was announced concerning whether the takeover of Cytec Industries Inc by Solvay for $75.25 per share is unfair to NYSE:CYT stockholders.

Investors who purchased shares of Cytec Industries Inc (NYSE:CYT) and currently hold any of those NYSE:CYT shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain officers and directors of Cytec Industries Inc breached their fiduciary duties owed to NYSE:CYT investors in connection with the proposed acquisition.

On July 29, 2015 Cytec Industries Inc. (NYSE:CYT) announced that it has entered into a merger agreement with Brussels-based Solvay. Under the terms of the proposed transaction shareholders of Cytec Industries Inc (NYSE:CYT) will receive $75.25 per NYSE:CYT share they hold.

However, the investigation concerns whether the offer is unfair to NYSE:CYT stockholders. More specifically, the investigation concerns whether the Cytec Industries Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Cytec Industries Inc reported that its annual Total Revenue rose from over $1.41 billion in 2011 to over $2 billion in 2014.

Shares of Cytec Industries Inc (NYSE:CYT) closed on August 7, 2015, at $74.00 per share.

Those who are current investors in Cytec Industries Inc (NYSE:CYT) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com